These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 23063659

  • 1. Loss of semaphorin-neuropilin-1 signaling causes dysmorphic vascularization reminiscent of alveolar capillary dysplasia.
    Joza S, Wang J, Fox E, Hillman V, Ackerley C, Post M.
    Am J Pathol; 2012 Dec; 181(6):2003-17. PubMed ID: 23063659
    [Abstract] [Full Text] [Related]

  • 2. Fetal, but not postnatal, deletion of semaphorin-neuropilin-1 signaling affects murine alveolar development.
    Joza S, Wang J, Tseu I, Ackerley C, Post M.
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):627-36. PubMed ID: 23713442
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma.
    Kawakami T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Abe Y, Osamura Y, Inoue H, Ueyama Y, Nakamura M.
    Cancer; 2002 Nov 15; 95(10):2196-201. PubMed ID: 12412174
    [Abstract] [Full Text] [Related]

  • 7. Effects of NRP1 on angiogenesis and vascular maturity in endothelial cells are dependent on the expression of SEMA4D.
    Lyu Z, Jin H, Yan Z, Hu K, Jiang H, Peng H, Zhuo H.
    Int J Mol Med; 2020 Oct 15; 46(4):1321-1334. PubMed ID: 32945351
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling.
    Bergé M, Allanic D, Bonnin P, de Montrion C, Richard J, Suc M, Boivin JF, Contrerès JO, Lockhart BP, Pocard M, Lévy BI, Tucker GC, Tobelem G, Merkulova-Rainon T.
    J Hepatol; 2011 Oct 15; 55(4):866-75. PubMed ID: 21338642
    [Abstract] [Full Text] [Related]

  • 11. Neuropilin-1 enforces extracellular matrix signalling via ABL1 to promote angiogenesis.
    Raimondi C.
    Biochem Soc Trans; 2014 Oct 15; 42(5):1429-34. PubMed ID: 25233427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R, Curry JM, Roy LD, Grover P, Haider J, Moore LJ, Wu ST, Kamesh A, Yazdanifar M, Ahrens WA, Leung T, Mukherjee P.
    Oncogene; 2016 Oct 27; 35(43):5608-5618. PubMed ID: 26804176
    [Abstract] [Full Text] [Related]

  • 15. Neuropilins in the Context of Tumor Vasculature.
    Niland S, Eble JA.
    Int J Mol Sci; 2019 Feb 01; 20(3):. PubMed ID: 30717262
    [Abstract] [Full Text] [Related]

  • 16. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.
    Oncogene; 2007 Aug 16; 26(38):5577-86. PubMed ID: 17369861
    [Abstract] [Full Text] [Related]

  • 17. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
    Mazurek AM, Olbryt M.
    Neoplasma; 2012 Aug 16; 59(1):43-51. PubMed ID: 22082309
    [Abstract] [Full Text] [Related]

  • 18. Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways.
    Salikhova A, Wang L, Lanahan AA, Liu M, Simons M, Leenders WP, Mukhopadhyay D, Horowitz A.
    Circ Res; 2008 Sep 12; 103(6):e71-9. PubMed ID: 18723443
    [Abstract] [Full Text] [Related]

  • 19. Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis.
    Fantin A, Herzog B, Mahmoud M, Yamaji M, Plein A, Denti L, Ruhrberg C, Zachary I.
    Development; 2014 Feb 12; 141(3):556-62. PubMed ID: 24401374
    [Abstract] [Full Text] [Related]

  • 20. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
    Pan Q, Chanthery Y, Liang WC, Stawicki S, Mak J, Rathore N, Tong RK, Kowalski J, Yee SF, Pacheco G, Ross S, Cheng Z, Le Couter J, Plowman G, Peale F, Koch AW, Wu Y, Bagri A, Tessier-Lavigne M, Watts RJ.
    Cancer Cell; 2007 Jan 12; 11(1):53-67. PubMed ID: 17222790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.